News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
US Partial Clinical Hold on Diamyd® Phase III Trial Lifted by the FDA
Monday, November 28, 2022Diamyd Medical has announced that the US Food and Drug Administration FDA has lifted the partial clinical hold on the confirmatory Phase III trial DIAGNODE The trial aims to evaluate the safety and efficacy of Diamyd a precision medicine and antigens...
Envirotainer significantly expands global CryoSure® network with new Singapore station
Friday, November 25, 2022Envirotainer the global market leader in secure cold chain solutions for shipment of pharmaceuticals has opened a new CryoSure station in Singapore This significantly expands global availability of the ultracold solution for the transportation of med...
Grünenthal and Kyowa Kirin International Announce Joint Venture Collaboration for Established Medicines Portfolio
Friday, November 25, 2022Kyowa Kirin Co Ltd a Japanbased global specialty pharmaceutical company and Grnenthal GmbH a global sciencebased privatelyowned pharmaceutical company are today announcing they have signed a Joint Venture Collaboration for Kyowa Kirin Internationals...
Iktos Partners with Medicines for Malaria Venture in Anti-Malarial Drug Discovery
Thursday, November 24, 2022Iktos a leader in Artificial Intelligence for new drug design today announced a collaboration with Medicines for Malaria Venture MMV a leading product development partnership PDP in the field of antimalarial drug research and development Under this c...
AcuCort signs its first commercial agreement for the company's drug Zeqmelit™
Thursday, November 24, 2022AcuCort AB announces that the company has signed an exclusive commercial agreement with the global biopharmaceutical company Kamada Ltd The agreement gives Kamada the exclusive right to the marketing and sales as well as the distribution of AcuCorts...
Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for Axitinib Tablets, 1 mg and 5 mg
Wednesday, November 23, 2022Glenmark Pharmaceuticals Inc USA Glenmark and Glenmark Pharmaceuticals Limited have reached a settlement agreement with Pfizer Inc PF Prism CV and PF Prism IMB BV Pfizer for Axitinib Tablets mg and mg the generic version of their Inlyta Tablets mg...
Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID
Wednesday, November 23, 2022Tevogen Bio a latestage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology neurology and virology announced today its intention
OKYO Pharma Announces U.S. IND Filing on OK-101 for the Treatment of Dry Eye Disease
Tuesday, November 22, 2022OKYO Pharma Limited an ophthalmologyfocused biopharmaceutical company which is developing OK to treat dry eye disease to address the significant unmet need in this multibilliondollar market today announced that it filed an Investigational New Drug IN...
Healiva® Acquires Critical Cell Therapy Manufacturing Assets From B. Braun
Tuesday, November 22, 2022Healiva a patientcentric company delivering lifeenhancing precision medicine for patients with chronic and acute wounds announced today the acquisition of critical manufacturing assets from B Braun Medical AG Switzerland an affiliate of German medica...
Upstaza™ Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Friday, November 18, 2022PTC Therapeutics Inc announced that Upstaza was granted authorization by the Medicines and Healthcare Products Regulatory Agency MHRA in Great Britain
